Evidence map›Paper›PMID 34279827›Full record

ArticleAdvances in experimental medicine and biology2021

COVID-19 Pandemic in Brazil: History, Characteristics, and Evolution.

Tamires Duarte Afonso Serdan, Yuanji Tang, Tiago Bertola Lobato, Flaviano Luis Rocha da Silva, Sherry Tang, Laureane Nunes Masi, Renata Gorjao, Ricardo Palacios, Tania Cristina Pithon-Curi, Rui Curi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tamires Duarte Afonso SerdanInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil. tamiresd.serdan@gmail.com.
Yuanji TangApplied NanoFemto Technologies, LLC, Lowell, MA, USA.
Tiago Bertola LobatoInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.
Flaviano Luis Rocha da SilvaInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.
Sherry TangKaiser Southern California Permanente Medical Group, Riverside, CA, USA.
Laureane Nunes MasiInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.
Renata GorjaoInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.
Ricardo PalaciosButantan Institute, Sao Paulo, Brazil.
Tania Cristina Pithon-CuriInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.
Rui CuriInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.
Sandro Massao HirabaraInterdisciplinary Program of Health Sciences, Cruzeiro do Sul University, Sao Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This chapter describes the eruption and spread of the SARS-COV-2 virus throughout Brazil. We also describe the governmental measures used to combat the virus, the regional influences impacting viral spreading, and the prevalence of the disease in different Brazilian subpopulations. It is hoped that such information will contribute to the control of the virus and help to prepare the region for future pandemics.

Indexed as

COVID-19PandemicsBrazilHumansPrevalenceSARS-CoV-2BrazilCOVID-19Governmental measuresPandemicRegional characteristicsSARS-CoV-2

Identifiers

PMID34279827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.